8FDY
Human GAR transformylase in complex with GAR substrate and AGF132 inhibitor
Summary for 8FDY
Entry DOI | 10.2210/pdb8fdy/pdb |
Descriptor | Phosphoribosylglycinamide formyltransferase, GLYCINAMIDE RIBONUCLEOTIDE, N-{5-[4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]pyridine-2-carbonyl}-L-glutamic acid, ... (4 entities in total) |
Functional Keywords | garftas, purine biosynthesis, monomer, transferase |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 23567.80 |
Authors | Wong-Roushar, J.,Dann III, C.E. (deposition date: 2022-12-05, release date: 2023-05-10, Last modification date: 2024-05-22) |
Primary citation | Tong, N.,Wong-Roushar, J.,Wallace-Povirk, A.,Shah, Y.,Nyman, M.C.,Katinas, J.M.,Schneider, M.,O'Connor, C.,Bao, X.,Kim, S.,Li, J.,Hou, Z.,Matherly, L.H.,Dann 3rd, C.E.,Gangjee, A. Multitargeted 6-Substituted Thieno[2,3- d ]pyrimidines as Folate Receptor-Selective Anticancer Agents that Inhibit Cytosolic and Mitochondrial One-Carbon Metabolism. Acs Pharmacol Transl Sci, 6:748-770, 2023 Cited by PubMed: 37200803DOI: 10.1021/acsptsci.3c00020 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.06 Å) |
Structure validation
Download full validation report